✦ LIBER ✦

Successful cessation of lamivudine using interferon in a patient with chronic hepatitis

✍ Scribed by Kazuhiko Hayashi; Yoshiaki Katano; Masatoshi Ishigami; Akihiro Itoh; Yoshiki Hirooka; Isao Nakano; Hidemi Goto

Book ID: 107648888
Publisher: Springer Japan
Year: 2009
Tongue: English
Weight: 211 KB
Volume: 2
Category: Article
ISSN: 1865-7257
DOI: 10.1007/s12328-009-0065-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of chronic delta hepatitis wit

Treatment of chronic delta hepatitis with lamivudine vs lamivudine + interferon vs interferon

✍ C. Yurdaydın; H. Bozkaya; F. O. Önder; H. Şentürk; H. Karaaslan; M. Akdoğan; H. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB

Comparison of interferon and lamivudine

Comparison of interferon and lamivudine treatment in Japanese patients with HBeAg positive chronic hepatitis B

✍ Yasuji Arase; Kenji Ikeda; Fumitaka Suzuki; Yoshiyuki Suzuki; Masahiro Kobayashi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 1 views

## Abstract The aim of this study was to elucidate the long‐term outcome after interferon (IFN) or lamivudine (LMV) treatment in Japanese patients with hepatitis B e antigen (HBeAg) positive chronic hepatitis B. Inclusion criteria were biopsy proven chronic hepatitis or liver cirrhosis, no history

Three-phase sequential combined treatmen

Three-phase sequential combined treatment with lamivudine and interferon in young patients with chronic hepatitis B

✍ A. Marrone; R. Zampino; G. Portella; M. Grimaldi; E. D. Mangoni; L. Santarpia; G 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

Hepatitis C viraemia rebound after “succ

Hepatitis C viraemia rebound after “successful” interferon therapy in patients with chronic non-A, non-B hepatitis

✍ Dr. J. A. Garson; S. Brillanti; C. Ring; P. Perini; M. Miglioli; L. Barbara 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 449 KB 👁 1 views

## Abstract A quantitative polymerase chain reaction (PCR) assay for hepatitis C viral RNA (HCV‐RNA) was used to monitor viraemia levels in six patients at multiple time points before, during, and after interferon therapy for chronic non‐A, non‐B hepatitis (NANBH). Prior to therapy, serum HCV‐RNA w

Successful treatment of hepatitis B-asso

Successful treatment of hepatitis B-associated leukocytoclastic vasculitis with lamivudine treatment in a child patient

✍ Ozge Surmali Onay; Esra Baskin; Figen Ozçay; Engin Melek; Oguz Canan; Banu Bilez 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 203 KB

A viral kinetic study using pegylated in

A viral kinetic study using pegylated interferon alfa-2b and/or lamivudine in patients with chronic hepatitis B/HBeAg negative

✍ Vassiliki-Anastasia Sypsa; Konstantinos Mimidis; Nicholas C. Tassopoulos; Dimitr 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB 👁 2 views

We studied viral dynamic parameters in 44 chronic hepatitis B/hepatitis B e antigen (HBeAg)(؊) patients treated with pegylated interferon alfa-2b (PEG-IFN) 100 or 200 g weekly or lamivudine 100 mg daily or the combination of PEG-IFN 100 or 200 g with lamivudine. Patients receiving PEG-IFN monotherap